Here is a comprehensive overview of bronchitis:
Bronchitis
Bronchitis refers to inflammation of the bronchial airways and exists in two distinct clinical forms: acute and chronic.
Acute Bronchitis
Definition & Causes
A common lower respiratory tract infection in both children and adults, characterized by cough, phlegm, hoarseness, or wheezing. Viral causes predominate in otherwise healthy patients — RSV and rhinovirus are the most common organisms, even during influenza season. Atypical bacteria such as Chlamydia pneumoniae and Mycoplasma pneumoniae account for a small minority of cases (~4% and ~2%, respectively).
Symptoms
- Productive or non-productive cough
- Hoarseness
- Wheezing (in some patients)
- Low-grade fever
- Phlegm/sputum production
Treatment
- Primarily supportive — the condition is self-limited in healthy individuals
- Air humidifiers, cough suppressants, antipyretic analgesics
- β-agonists are sometimes prescribed, but no evidence supports benefit without measurable airway obstruction
- Antibiotics: Controversial. Because the cause is usually viral, antibiotics are frequently overprescribed (a source of antibiotic resistance). May be considered after 10–14 days of productive cough, especially in smokers or those with underlying pulmonary disease. Choice of antibiotic (macrolide vs. amoxicillin) has little proven impact.
Patients with underlying pulmonary disease or smokers are at higher risk for secondary pneumonia or COPD exacerbation.
Chronic Bronchitis
Definition
Clinically defined as a persistent productive cough for ≥3 consecutive months in ≥2 consecutive years. Unlike emphysema (which is defined anatomically), chronic bronchitis is a clinical diagnosis.
Risk Factors
- Cigarette smoking (primary cause)
- Air pollutants: sulfur dioxide, nitrogen dioxide
- Urban residence in smog-heavy environments
Pathogenesis
Environmental irritants cause:
- Hypertrophy of mucous glands in the trachea and bronchi
- Increase in goblet cells in smaller bronchi and bronchioles
- Inflammation — macrophages, neutrophils, and lymphocytes (notably no eosinophils, distinguishing it from asthma)
- Cytokines (especially IL-13 from T cells) mediate many of these effects
- Increased mucin expression and neutrophil elastase from tobacco smoke exposure
Airflow obstruction arises from small airway disease (chronic bronchiolitis) — mucous plugging, inflammation, and bronchiolar wall fibrosis — rather than from the large airway changes.
Morphology (Pathology)
- Hyperemic, edematous bronchial mucosa covered by mucinous/mucopurulent secretions
- Enlargement of submucosal mucous glands — assessed by the Reid index (gland layer thickness / bronchial wall thickness; normally <0.4; elevated in chronic bronchitis)
- Goblet cell metaplasia, mucus plugging, and fibrosis in small airways
- Severe cases: bronchiolitis obliterans (complete luminal obliteration by fibrosis)
- Emphysematous changes often coexist
Clinical Variants
- Asthmatic bronchitis: intermittent bronchospasm and wheezing with hyperresponsive airways
- Obstructive chronic bronchitis (in heavy smokers): chronic outflow obstruction, usually with associated emphysema → part of COPD
Acute vs. Chronic Bronchitis — Summary
| Feature | Acute | Chronic |
|---|
| Duration | Days–weeks (self-limited) | ≥3 months/year for ≥2 years |
| Cause | Viral (mainly) | Smoking, pollutants |
| Airflow obstruction | Usually absent | Present (in advanced disease) |
| Treatment | Supportive ± antibiotics | Smoking cessation, bronchodilators, mucolytics |
| Key risk | Secondary pneumonia | COPD progression |
Sources: Textbook of Family Medicine 9e; Robbins & Kumar Basic Pathology
A recent 2024 meta-analysis (PMID
39413571) confirmed that
mucolytics show efficacy and safety in stable COPD/chronic bronchitis, supporting their use in management.
Would you like to go deeper into any particular aspect — such as COPD overlap, diagnosis, or specific treatments?